Recent Publications of the Psychosocial Research and Depression Clinic
Jarrett, R. B., Schaffer, M., McIntire, D., Witt-Browder, A., Kraft, D., Risser, R. C., (1999) Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind placebo controlled trial. Archives of General Psychiatry, 56, 431-43.
Jarrett, R. B., Kraft, D., Doyle, J., Foster, B. M., Eaves, G., & Silver, P. (2001) Preventing recurrent depression using cognitive therapy with and without a continuation phase: A randomized clinical trial. Archives of General Psychiatry, 58, 381-388.
Vittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007) Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive therapy’s effects. Journal of Consulting and Clinical Psychology, 75, 475-488.
Jarrett, R. B., Vittengl, J. R., & Clark, L. A. (2008). How much cognitive therapy, for which patients, will prevent relapse? Journal of Affective Disorders, 111, 185-192. PMCID: PMC2629435. Selected for abstracting, How much is too much? Practical advice regarding follow-up treatment. Clinician's Research Digest: Briefings in Behavioral Science, 26(6), 6.
Kennard, B. D., Emslie, G. J., Mayes, T. L., Nightingale-Teresi, J., Nakonezny, P., Hughes, J. L., Jones, J. M., Tao, R., Stewart, S. M., & Jarrett, R. B. (2008). Cognitive behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 47(12), 1395-1404. PMCID: PMC2826176
Vittengl, J. V., Clark, L. A., & Jarrett, R. B. (2009). Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression. Journal of Affective Disorders, 112, 139-143. PMCID: PMC2613181
Vittengl, J. V., Clark, L. A., & Jarrett, R. B. (2009). Continuation phase cognitive therapy’s effects on remission and recovery from depression. Journal of Consulting and Clinical Psychology, 77(2), 367-371.
Jarrett, R. B., & Thase, M. E. (2010). Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: Design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up. Contemporary Clinical Trials, 31(4), 355-377. doi:10.1016/j.cct.2010.04.004.
Taylor, D. J., Walters, H. M., Vittengl, J. V., Krebaum, S., & Jarrett, R. B. (2010). Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence? Journal of Affective Disorders, 123, 181-187.
Vittengl, J. R., Clark, L. A., & Jarrett, R. B. (2010). Moderators of continuation phase cognitive therapy's effects on relapse, recurrence, remission, and recovery from depression. Behaviour Research and Therapy, 48(6), 449-458.
Jarrett, R. B., Vittengl, J. R., Thase, M. E., & Clark, L. A. (2011, February). Skills of Cognitive Therapy (SoCT): A new measure of patients’ comprehension and use. Psychological Assessment. Advance online publication. doi: 10.1037/a0022485.